News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
845,494 Results
Type
Article (86439)
Company Profile (655)
Press Release (758400)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232649)
Career Advice (4126)
Deals (39718)
Drug Delivery (129)
Drug Development (90959)
Employer Resources (198)
FDA (18095)
Job Trends (17332)
News (396386)
Policy (39743)
Tag
Academia (2998)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56826)
ALS (98)
Alzheimer's disease (1494)
Antibody-drug conjugate (ADC) (152)
Approvals (18064)
Artificial intelligence (298)
Autoimmune disease (27)
Automation (16)
Bankruptcy (404)
Best Places to Work (12622)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (448)
Bladder cancer (82)
Brain cancer (30)
Breast cancer (294)
Cancer (2409)
Cardiovascular disease (203)
Career advice (3533)
Career pathing (34)
CAR-T (172)
Cell therapy (480)
Cervical cancer (20)
Clinical research (73356)
Collaboration (907)
Compensation (548)
Complete response letters (30)
COVID-19 (2864)
CRISPR (48)
C-suite (264)
Cystic fibrosis (106)
Data (2264)
Decentralized trials (2)
Denatured (45)
Depression (54)
Diabetes (291)
Diagnostics (6908)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (132)
Drug pricing (126)
Drug shortages (33)
Duchenne muscular dystrophy (100)
Earnings (96602)
Editorial (44)
Employer branding (25)
Employer resources (167)
Events (129906)
Executive appointments (769)
FDA (19409)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (796)
Gene editing (119)
Generative AI (26)
Gene therapy (355)
GLP-1 (848)
Government (5158)
Grass and pollen (6)
Guidances (65)
Healthcare (20870)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (146)
Indications (30)
Infectious disease (3021)
Inflammatory bowel disease (152)
Inflation Reduction Act (11)
Influenza (54)
Intellectual property (101)
Interviews (812)
IPO (17813)
IRA (51)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (554)
Leadership (23)
Legal (10113)
Liver cancer (81)
Lung cancer (342)
Lymphoma (159)
Machine learning (7)
Management (65)
Manufacturing (346)
MASH (75)
Medical device (14609)
Medtech (14614)
Mergers & acquisitions (22442)
Metabolic disorders (779)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (111)
Neuropsychiatric disorders (34)
Neuroscience (2093)
NextGen: Class of 2025 (7667)
Non-profit (5081)
Now hiring (40)
Obesity (420)
Opinion (274)
Ovarian cancer (78)
Pain (98)
Pancreatic cancer (86)
Parkinson's disease (159)
Partnered (23)
Patents (248)
Patient recruitment (116)
Peanut (51)
People (65277)
Pharmaceutical (137)
Pharmacy benefit managers (21)
Phase I (22643)
Phase II (31852)
Phase III (24001)
Pipeline (1248)
Policy (170)
Postmarket research (3552)
Preclinical (10213)
Press Release (72)
Prostate cancer (112)
Psychedelics (38)
Radiopharmaceuticals (268)
Rare diseases (428)
Real estate (7392)
Recruiting (75)
Regulatory (26779)
Reports (57)
Research institute (2654)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (49)
Schizophrenia (80)
Series A (142)
Series B (90)
Service/supplier (28)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4291)
State (2)
Stomach cancer (15)
Supply chain (76)
Tariffs (45)
The Weekly (82)
Vaccines (809)
Venture capitalists (44)
Weight loss (303)
Women's health (40)
Worklife (20)
Date
Today (209)
Last 7 days (934)
Last 30 days (2813)
Last 365 days (35216)
2025 (11422)
2024 (37750)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (60)
Alaska (7)
Arizona (269)
Arkansas (14)
Asia (50111)
Australia (8827)
California (6385)
Canada (2052)
China (560)
Colorado (280)
Connecticut (288)
Delaware (158)
Europe (114904)
Florida (937)
Georgia (220)
Hawaii (1)
Idaho (64)
Illinois (623)
India (30)
Indiana (332)
Iowa (12)
Japan (169)
Kansas (111)
Kentucky (27)
Louisiana (13)
Maine (67)
Maryland (964)
Massachusetts (4904)
Michigan (239)
Minnesota (416)
Mississippi (2)
Missouri (86)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (68)
New Jersey (1807)
New Mexico (31)
New York (1813)
North Carolina (1119)
North Dakota (9)
Northern California (2736)
Ohio (219)
Oklahoma (15)
Oregon (46)
Pennsylvania (1418)
Puerto Rico (13)
Rhode Island (35)
South America (1652)
South Carolina (24)
South Dakota (1)
Southern California (2360)
Tennessee (103)
Texas (951)
United States (24534)
Utah (189)
Virginia (165)
Washington D.C. (68)
Washington State (597)
West Virginia (3)
Wisconsin (60)
845,494 Results for "pharma bio serv inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025
March 18, 2025
·
2 min read
Press Releases
Pharma-Bio Serv Announces Special Dividend
January 30, 2025
·
2 min read
Press Releases
Pharma-Bio Serv Announces Full Year Results
January 30, 2025
·
3 min read
Business
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024
Pharma-Bio Serv, Inc. announced that revenues for the three and six months ended April 30, 2024 were approximately $2.4 and $4.8, million, respectively, a decrease of approximately $2.2 and $4.0 million when compared to the same periods last year.
June 14, 2024
·
2 min read
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024
Pharma-Bio Serv, Inc. (“Pharma-Bio Serv” or the “Company”) (OTCQB:PBSV) today announced that revenues for the quarter ended January 31, 2024 were approximately $2.4 million, a decrease of approximately $1.9 million when compared to the same period last year.
March 18, 2024
·
2 min read
Pharma-Bio Serv Announces Full Year Results - Jan 29, 2024
Pharma-Bio Serv, Inc. announced that revenues for the year ended October 31, 2023 were approximately $17.0 million, a decrease of approximately $2.4 million when compared to last year.
January 29, 2024
·
2 min read
Deals
Pharma-Bio Serv Announces Special Dividend - December 21, 2023
Pharma-Bio Serv, Inc. today announced that the Board of Directors approved a Special Dividend of $0.075 per share for Shareholders.
December 21, 2023
·
2 min read
Press Releases
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024
September 17, 2024
·
2 min read
Press Releases
Nxera Pharma’s Partner Tempero Bio Initiates Phase 2 Trial with TMP-301 for Alcohol Use Disorder
March 25, 2025
·
4 min read
Business
Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023
Pharma-Bio Serv, Inc. (“Pharma-Bio Serv” or the “Company”) (OTCQB:PBSV) today announced that net income for the three and nine months ended July 31, 2023 was approximately $0.5 and $1.4 million, respectively, an increase of approximately $0.2 and $0.5 million, when compared to the same periods last year.
September 14, 2023
·
2 min read
1 of 84,550
Next
